BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT

BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT

The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who have BRAFV600mutation. This work will discuss new...

Full description

Bibliographic Details
Main Authors: Ivana Inić, Momcilo Inić, Zorka Inić, Milan Zegarac, Aleksandar Martinović, Miomir Šašić, Miloš Bracanović, Gordana Pupić
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2014-09-01
Series:Acta Medica Medianae
Subjects:
metastatic melanoma
BRAF V600 mutation
treatment
Online Access:http://publisher.medfak.ni.ac.rs/2014-html/3-broj/Ivana%20Inic-BRAF.pdf

Internet

http://publisher.medfak.ni.ac.rs/2014-html/3-broj/Ivana%20Inic-BRAF.pdf

Similar Items